The Russian Ministry of Health has clarified that the newly introduced requirements for providing prescription information to the monitoring system during the sale of certain prescription medicines in pharmacies will not cause drug shortages. This update is outlined in the current official document and reported by RIA News.
Officials explain that the changes are technical in nature and will mainly influence the operational algorithms used by pharmacy staff. The adjustments are not expected to affect the availability of medicines for the population.
Representatives from the Ministry of Health also noted that, at present, information on prescriptions for subsidized medicines and remotely sold drugs is already entered into the monitoring system. They stressed that the new rules, which take effect on September 1 this year, will not reduce the accessibility of medicines for citizens.
Earlier, State Duma deputy Nina Ostanina expressed concern about the forthcoming requirements for selling prescription drugs in pharmacies. She argued that tightening these rules could pose difficulties for ordinary citizens and suggested seeking clarification from the government on the issue.
Additionally, it was mentioned by a former medical professional that certain medical guidance related to diabetes risk reduction is part of ongoing discussions, highlighting the broader context of health information and treatment decisions, including prescription practices and monitoring processes.